Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cancer CARE Beyond Walls - A Pilot of a Randomized, Pragmatic Trial of Cancer Directed Therapy Administration in the Patients' Homes Versus in Clinic

NCT05969860 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05969860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05969860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cancer CARE Beyond Walls - A Pilot of a Randomized, Pragmatic Trial of Cancer Directed Therapy Administration in the Patients' Homes Versus in Clinic
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Recruiting
Start date
August 23, 2023
Completion date
January 1, 2027
Enrollment
220 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced anal carcinoma, advanced appendix carcinoma, advanced basal cell carcinoma, advanced biliary tract carcinoma, advanced bladder carcinoma, advanced breast carcinoma, advanced carcinoid tumor, advanced cervical carcinoma, advanced cholangiocarcinoma, advanced colorectal carcinoma, advanced endometrial carcinoma, advanced esophageal carcinoma, advanced fallopian tube carcinoma, advanced gastric carcinoma, advanced gastroesophageal junction adenocarcinoma, advanced glioblastoma, advanced head and neck carcinoma, advanced hepatocellular carcinoma, advanced her2 positive breast carcinoma, advanced liver carcinoma, advanced lung carcinoma, advanced lung small cell carcinoma, advanced lymphoma, advanced malignant germ cell tumor, advanced malignant solid neoplasm, advanced malignant testicular neoplasm, advanced melanoma, advanced merkel cell carcinoma, advanced neuroendocrine carcinoma, advanced ovarian carcinoma, advanced pancreatic carcinoma, advanced penile carcinoma, advanced primary malignant central nervous system neoplasm, advanced prostate carcinoma, advanced prostate small cell neuroendocrine carcinoma, advanced renal cell carcinoma, advanced sarcoma, advanced skin squamous cell carcinoma, advanced urethral carcinoma, advanced vaginal carcinoma, advanced vulvar carcinoma, hematopoietic and lymphoid system neoplasm, multiple myeloma, myelodysplastic syndrome